Wu, Y. L., Fukuoka, M., Mok, T. S., Saijo, N., Thongprasert, S., Yang, J. C., . . . Rukazenkov, Y. (2018). Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study.
استشهاد بنمط شيكاغوWu, Yi Long, Masahiro Fukuoka, Tony S.K Mok, Nagahiro Saijo, Sumitra Thongprasert, James C.H Yang, Da Tong Chu, Jin Ji Yang, و Yuri Rukazenkov. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.
MLA استشهادWu, Yi Long, et al. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.